Health and Healthcare Systems

3 reasons we can't compare countries' coronavirus responses

People wear face masks at Shinagawa station during the rush hour after the government expanded a state of emergency to include the entire country following the coronavirus disease (COVID-19) outbreak, in Tokyo, Japan, April 20, 2020.REUTERS/Kim Kyung-Hoon     TPX IMAGES OF THE DAY - RC208G9LDBRT

Demographics play a significant role in how different countries have been affected. Image: REUTERS/Kim Kyung-Hoon

Harry Kretchmer
Senior Writer, Forum Agenda
  • Research has questioned the usefulness of death rates in judging countries’ success in battling COVID-19.
  • There are high numbers of “excess deaths” in many countries, much higher than deaths officially attributed to the coronavirus.
  • Geography and demographics play a significant role in how countries have been affected.

Some countries have been praised for their swift responses to the coronavirus, while others have been criticized for doing too little, too late.

But an increasing focus on data is leading to questions over whether we are comparing like with like. After all, the way nations record tests and deaths varies, and there may be societal differences that need to be considered.

Have you read?

Here are three reasons why direct comparisons between countries are challenging.

1. Death rates are complicated

Coronavirus china virus health healthcare who world health organization disease deaths pandemic epidemic worries concerns Health virus contagious contagion viruses diseases disease lab laboratory doctor health dr nurse medical medicine drugs vaccines vaccinations inoculations technology testing test medicinal biotechnology biotech biology chemistry physics microscope research influenza flu cold common cold bug risk symptomes respiratory china iran italy europe asia america south america north washing hands wash hands coughs sneezes spread spreading precaution precautions health warning covid 19 cov SARS 2019ncov wuhan sarscow wuhanpneumonia  pneumonia outbreak patients unhealthy fatality mortality elderly old elder age serious death deathly deadly
Official COVID-19 figures don’t fully explain the Image: London Business School

There are a number of reasons to be sceptical about figures telling us one country has a worse death rate than another. The first is the issue of “excess deaths” – a temporary increase in the death rate, compared with historic trends. The large number of excess deaths currently seen in many countries is much higher than the official numbers of deaths attributed to COVID-19.

A number of studies have looked at this, from the London Business School to The New York Times. The Financial Times says globally excess deaths were around 122,000, over the weeks of different outbreaks in March and April – much higher than the 77,000 official COVID-19 deaths reported for the same places and time periods.

Discover

What is the World Economic Forum doing about the coronavirus outbreak?

There is some debate over the reasons for this discrepancy, ranging from underreporting of coronavirus cases, to some patients avoiding hospital and dying from preventable conditions.

David Spiegelhalter, statistician and professor at the UK’s University of Cambridge, told The Financial Times: “There are so many questions about the rise we’ve seen in deaths that have not got [COVID-19] on the death certificate, yet you feel are inevitably linked in some way to this epidemic.”

When deaths are measured per 100,000 of countries’ populations, Belgium has the highest death rate.
When deaths are measured per 100,000 of countries’ populations, Belgium has the highest death rate. Image: Johns Hopkins University

Another thing to consider is the size of a country’s population. When viewed through this lens, Belgium has the highest rate. Although the US has seen by far the most deaths – currently at more than 58,000 – Belgium has been hit hardest when deaths are counted per 100,000 of the population.

2. Countries collect data differently

There are widespread variations in data collection, which has an impact on perceptions of a country's response to the crisis.

The daily figure for COVID-19 deaths in a country might, for example, only include those dying in hospitals (this was the case in England, until late April). Other nations, such as France, included deaths in care homes in their figures.

Numbers of COVID-19 cases are also recorded differently in many places, with some including pending tests and others leaving out the results from some labs.

The total number of COVID-19 cases in China will never be known.
The total number of COVID-19 cases in China will never be known. Image: Imperial College London via BBC

There are big differences in approaches to testing too. The UK has prioritized testing frontline workers and people who are so ill they need to be hospitalized. Other countries, like South Korea, have adopted blanket testing models. This means one country’s data may be less complete than others, making its death rate per confirmed case look relatively high.

3. Countries are very different

Countries and continents are very different. Africa, for example, has a much younger population than Europe – a factor some experts say may help explain why it has, to date, reported a relatively small number of confirmed deaths.

There are striking differences in the spread of COVID-19 between rural and urban areas within a country. Epidemiologist Professor Christl Donnelly of Imperial College London told BBC Radio 4’s statistics programme More or Less: “The more dense the population, the more you would expect transmission to happen.”

That said, some rural communities have become virus hot spots, and well-equipped cities such as Singapore had success in containing the virus – so generalizations are difficult.

All of which suggest that, while we may be able to draw some conclusions about the success of nations’ COVID-19 responses, we should exercise caution when making direct comparisons.

Don't miss any update on this topic

Create a free account and access your personalized content collection with our latest publications and analyses.

Sign up for free

License and Republishing

World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.

The views expressed in this article are those of the author alone and not the World Economic Forum.

Stay up to date:

COVID-19

Related topics:
Health and Healthcare SystemsEconomic Growth
Share:
The Big Picture
Explore and monitor how COVID-19 is affecting economies, industries and global issues
A hand holding a looking glass by a lake
Crowdsource Innovation
Get involved with our crowdsourced digital platform to deliver impact at scale
World Economic Forum logo
Global Agenda

The Agenda Weekly

A weekly update of the most important issues driving the global agenda

Subscribe today

You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.

Accelerating action against breast and cervical cancer in Africa: Global women's health alliance expands to Zambia

Kennedy Lishimpi and Emily Fitzgerald

November 17, 2024

How COVID-19 unleashed a wave of medical oxygen innovation

About us

Engage with us

  • Sign in
  • Partner with us
  • Become a member
  • Sign up for our press releases
  • Subscribe to our newsletters
  • Contact us

Quick links

Language editions

Privacy Policy & Terms of Service

Sitemap

© 2024 World Economic Forum